MBN-101

DRUG2 trials

Sponsors

Microbion Corporation

Conditions

Bacterial InfectionDiabetic Foot Infection

Phase 1

A Trial to Assess Safety and Efficacy of Topical MBN-101 in Patients With Moderate/ Severe DFI

CompletedNCT02723539

Microbion CorporationDiabetic Foot Infection

Start: 2017-03-06End: 2019-07-26Updated: 2020-07-02

Phase 2

Study to Assess Safety and Clinical Activity of Local MBN-101 in Treatment of Infected Bone Sites

CompletedNCT02436876

Microbion CorporationBacterial Infection

Start: 2016-05-24End: 2018-07-26Updated: 2021-09-30

Related Papers

Topical pravibismane as adjunctive therapy for moderate or severe diabetic foot infections: A phase 1b randomized, multicenter, double‐blind, placebo‐controlled trial

International Wound Journal2024-04-015 citations